130 related articles for article (PubMed ID: 9045887)
1. Molecular mechanisms of the development of human disease caused by RET mutations.
Romeo G
Jpn J Cancer Res; 1997 Jan; 88(1):Inside front cover. PubMed ID: 9045887
[No Abstract] [Full Text] [Related]
2. RET proto-oncogene: role in kidney development and molecular pathology.
Salomon R; Attie T; Amiel J; Pelet A; Niaudet P; Lyonnet S
Adv Nephrol Necker Hosp; 1998; 28():401-17. PubMed ID: 9890001
[No Abstract] [Full Text] [Related]
3. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.
Ohiwa M; Murakami H; Iwashita T; Asai N; Iwata Y; Imai T; Funahashi H; Takagi H; Takahashi M
Biochem Biophys Res Commun; 1997 Aug; 237(3):747-51. PubMed ID: 9299438
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
Gil L; Azañedo M; Pollán M; Cristobal E; Arribas B; García-Albert L; García-Sáiz A; Maestro ML; Torres A; Menárguez J; Rojas JM
Int J Cancer; 2002 May; 99(2):299-304. PubMed ID: 11979448
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Ponder BA
Cancer Surv; 1995; 25():195-205. PubMed ID: 8718519
[No Abstract] [Full Text] [Related]
9. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
[TBL] [Abstract][Full Text] [Related]
10. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Takahashi M; Iwashita T; Santoro M; Lyonnet S; Lenoir GM; Billaud M
Hum Mutat; 1999; 13(4):331-6. PubMed ID: 10220148
[TBL] [Abstract][Full Text] [Related]
11. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
Murakami H; Iwashita T; Asai N; Shimono Y; Iwata Y; Kawai K; Takahashi M
Biochem Biophys Res Commun; 1999 Aug; 262(1):68-75. PubMed ID: 10448070
[TBL] [Abstract][Full Text] [Related]
12. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.
Hayashi Y; Iwashita T; Murakamai H; Kato Y; Kawai K; Kurokawa K; Tohnai I; Ueda M; Takahashi M
Biochem Biophys Res Commun; 2001 Mar; 281(3):682-9. PubMed ID: 11237712
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
[TBL] [Abstract][Full Text] [Related]
14. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.
Watanabe T; Ichihara M; Hashimoto M; Shimono K; Shimoyama Y; Nagasaka T; Murakumo Y; Murakami H; Sugiura H; Iwata H; Ishiguro N; Takahashi M
Am J Pathol; 2002 Jul; 161(1):249-56. PubMed ID: 12107109
[TBL] [Abstract][Full Text] [Related]
16. GDNF family neurotrophic factor signaling: four masters, one servant?
Airaksinen MS; Titievsky A; Saarma M
Mol Cell Neurosci; 1999 May; 13(5):313-25. PubMed ID: 10356294
[No Abstract] [Full Text] [Related]
17. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
[TBL] [Abstract][Full Text] [Related]
18. Functional receptor for GDNF encoded by the c-ret proto-oncogene.
Trupp M; Arenas E; Fainzilber M; Nilsson AS; Sieber BA; Grigoriou M; Kilkenny C; Salazar-Grueso E; Pachnis V; Arumäe U
Nature; 1996 Jun; 381(6585):785-9. PubMed ID: 8657281
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
20. Molecular biology of the MEN2 gene.
Santoro M; Melillo RM; Carlomagno F; Visconti R; De Vita G; Salvatore G; Lupoli G; Fusco A; Vecchio G
J Intern Med; 1998 Jun; 243(6):505-8. PubMed ID: 9681850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
